ZDHHC22 Antibodies

Santa Cruz Biotechnology delivers a wide array of ZDHHC22 monoclonal antibodies for research focused on understanding ZDHHC22 protein functions. ZDHHC22 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).ZDHHC22, a member of the zinc finger DHHC-type palmitoyltransferase family, plays a crucial role in the post-translational modification of proteins through palmitoylation, which is essential for membrane localization and protein stability. ZDHHC22 is involved in various cellular processes, including signal transduction and protein trafficking, making it significant in the study of cellular dynamics and disease mechanisms. Research has shown that ZDHHC22 may influence cellular pathways related to neurodegenerative diseases and other pathological conditions. Understanding ZDHHC22 function continues to reveal new insights about its biological significance and potential therapeutic applications. Investigating ZDHHC22 can lead to breakthroughs in understanding disease progression and potential treatment strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of ZDHHC22 and its impact on human health.